SOLEXA, INC. WARRANT TO PURCHASE COMMON STOCK1Solexa, Inc. • April 26th, 2005 • Medicinal chemicals & botanical products • California
This Certifies That, for value received, [___], or assigns (the “Holder”), is entitled to subscribe for and purchase at the Exercise Price (defined below) from Solexa, Inc., a Delaware corporation, with its principal office at 25861 Industrial Boulevard, Hayward, CA 94545 (the “Company”) up to [___] shares of the common stock of the Company, par value $0.01 per share (the “Common Stock”).
SOLEXA, INC. SECURITIES PURCHASE AGREEMENT APRIL 21, 2005Securities Purchase Agreement • April 26th, 2005 • Solexa, Inc. • Medicinal chemicals & botanical products • California
This Securities Purchase Agreement (this “Agreement”) is made as of April 21, 2005, by and among Solexa, Inc. , a Delaware corporation (the “Company”) with its principal office at 25861 Industrial Boulevard, Hayward, California 94545, and the individuals and entities identified on the signature pages hereto (the “Purchasers”).
Solexa, Inc. Letterhead]Solexa, Inc. • April 26th, 2005 • Medicinal chemicals & botanical products
This purpose of this letter is to confirm the understanding between Solexa, Inc., a Delaware company (the “Company”)and ValueAct Capital Master Fund, L.P. (“ValueAct”) in connection with the Company’s private placement of common stock and warrants pursuant to that certain Securities Purchase Agreement, dated April 21, 2005, by and between the Company and the individuals and entities identified on the signature pages hereto (the “Purchase Agreement”).
AMENDED AND RESTATED COMPANY SUPPORT AGREEMENTCompany Support Agreement • April 26th, 2005 • Solexa, Inc. • Medicinal chemicals & botanical products • Delaware
This Amended and Restated Company Support Agreement (the “Agreement”) is made and entered into as of April 21, 2005, between Solexa, Inc., a Delaware corporation (formerly Lynx Therapeutics, Inc.) (the “Company”), and the undersigned stockholder (“Holder”) of the Company.
